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Abstract
ADAMTS20 (A disintegrin-like and metalloprotease domain with thrombospondin type-1 motifs) is a member of a family of
secreted metalloproteases that can process a variety of extracellular matrix (ECM) components and secreted molecules.
Adamts20 mutations in belted (bt) mice cause white spotting of the dorsal and ventral torso, indicative of defective neural
crest (NC)-derived melanoblast development. The expression pattern of Adamts20 in dermal mesenchymal cells adjacent to
migrating melanoblasts led us to initially propose that Adamts20 regulated melanoblast migration. However, using a Dct-
LacZ transgene to track melanoblast development, we determined that melanoblasts were distributed normally in whole
mount E12.5 bt/bt embryos, but were specifically reduced in the trunk of E13.5 bt/bt embryos due to a seven-fold higher
rate of apoptosis. The melanoblast defect was exacerbated in newborn skin and embryos from bt/bt animals that were also
haploinsufficient for Adamts9, a close homolog of Adamts20, indicating that these metalloproteases functionally overlap in
melanoblast development. We identified two potential mechanisms by which Adamts20 may regulate melanoblast survival.
First, skin explant cultures demonstrated that Adamts20 was required for melanoblasts to respond to soluble Kit ligand
(sKitl). In support of this requirement, bt/bt;Kit
tm1Alf/+ and bt/bt;Kitl
Sl/+ mice exhibited synergistically increased spotting.
Second, ADAMTS20 cleaved the aggregating proteoglycan versican in vitro and was necessary for versican processing in
vivo, raising the possibility that versican can participate in melanoblast development. These findings reveal previously
unrecognized roles for Adamts proteases in cell survival and in mediating Kit signaling during melanoblast colonization of
the skin. Our results have implications not only for understanding mechanisms of NC-derived melanoblast development but
also provide insights on novel biological functions of secreted metalloproteases.
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Introduction
A disintegrin-like and metalloprotease with thrombospondin
type-1 motifs (ADAMTS) metalloproteases constitute a large
family of 19 zinc-dependent proteolytic enzymes that are distantly
related to both the A disintegrin and metalloproteinase (ADAM)
family, and to the matrix metalloproteinases (MMPs) [1,2]. In
contrast to the ADAM proteases that are membrane anchored,
ADAMTS proteases are secreted; however, some may be
considered as operational cell-surface proteases as they bind to
the cell surface. Some ADAMTS proteases, such as ADAMTS10
(GeneID: 224697), ADAMTS13 (GeneID: 279028), and the
procollagen amino-propeptidases (e.g. ADAMTS2), are highly
specialized; others process a variety of substrates within the
extracellular matrix (ECM), including chondroitin sulfate proteo-
glycans (CSPGs), such as aggrecan (GeneID: 11595) and versican
(GeneID: 13003). Mouse models harboring mutations in
ADAMTS family members have demonstrated the importance
of these proteases during development. In some cases mutant
phenotypes can be attributed to a failure to cleave specific
substrates [3–7]. Mutation or dysregulation of ADAMTS
proteases is associated with inherited and acquired pathologies
including Ehlers-Danlos syndrome VIIC (OMIM#225410),
thrombocytopenic purpura (OMIM#274150), Weill-Marchesani
syndrome (OMIM#277600) and arthritis [5,8–10].
Among the animal mutants in Adamts proteases is a classical
white-spotted mouse named belted (bt), so named because it
contains white spots in the lumbar region creating the appearance
of a belt [11–13]. Sequencing of three of the twelve known alleles
of belted—bt
Bei1, bt
Mri1, and bt (Mouse Genome Informatics, MGI:
2660628)—revealed nonsense or missense mutations in Adamts20,
thus implicating metalloproteases in skin pigmentation [12].
Analyses of white spotting mutants suggest that such phenotypes
are often due to defective development of neural crest (NC)-
derived melanoblasts that produce pigment of the integument
(skin, hair, feathers, and scales), inner ear, and eye [14,15].
Melanoblasts develop from a subset of NC that emigrate from the
neural tube and overlying ectoderm and migrate dorso-laterally
relative to the neural tube through prospective dermal mesenchyme
(embryonic day (E) 8.5-E9.5) [15,16]. Subsequently, the melano-
blasts differentiate and expand (E9.5-E13.5), migrate into the
epidermis and hair follicle (E13.5-E15.5), and eventually produce
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tyrosine kinase Kit (GeneID: 16590) and its ligand, Kit ligand (Kitl,
GeneID: 17311), regulate melanoblast development. Kit and Kitl act
throughout melanoblast development, with independent require-
ments for melanoblast survival, proliferation and migration [17–23].
Kit is expressed on melanoblasts, and Kitl is expressed in the dermis
and in dermal mesenchymal condensations and papillae [21,24–26].
Similar to Kitl, Adamts20 is expressed in dermal mesenchymal
cells adjacent to and in advance of migrating melanoblasts
throughout their development. This expression pattern led us to
initially propose that the bt phenotype was caused by defective
melanoblast migration [12]. This hypothesis was also based upon
the observation that the Adamts20 ortholog Gon-1 (GeneID:
177850) is essential for gonadal morphogenesis and distal tip cell
migration in C.elegans [27–29]. The current study tests our
hypothesis by performing extensive characterization of melano-
blast development in bt/bt embryos. Our findings suggest that
Adamts20 mutant mice exhibit white spotting in a belted pattern
due to a combination of regional variation of melanoblast number,
increased apoptosis, and functional overlap with Adamts9 (GeneID:
101401). Furthermore, our analyses of bt/bt embryos indicate that
defective Kit signaling and versican processing may explain the
failure of melanoblasts to develop properly.
Results
Genetic and Molecular Characterization of a New Belted
Allele
Adamts20 mutant mice exhibit white spotting in the lumbar
region on both dorsal and ventral surfaces, frequently resulting in
the appearance of a white belt in recessive animals (Figure 1A)
[11–13]. For these studies an allele of bt on an inbred C57BL/6
background was used, as different genetic backgrounds can affect
the expressivity of the bt phenotype [30,31]. Since an Adamts20
mutation had not been specifically demonstrated in this particular
bt allele, a complementation cross was performed between these bt
mice and bt
Bei1/+ mice. Seven out of 10 animals born exhibited a
bt phenotype, consistent with the expected Mendelian ratios (50%
bt) and indicative of a recessive allele of bt. This allele has now been
designated bt
9J and is listed at MGI.
The Adamts20 gene was sequenced from bt
9J/bt
9J genomic DNA
in order to identify the molecular lesion. A single C to T point
mutation was identified at nucleotide 2451, which is predicted to
cause a missense mutation (Leu761Phe) in the spacer domain of
ADAMTS20. The leucine residue mutated in bt
9J mice is present
in both mouse and human Adamts20 genes and is highly conserved
among all Adamts mouse genes (present in 15 of the 19 genes). This
suggests that Leu761 may be a critical residue for ADAMTS20
folding or for enzymatic function. We designed a Taqman
TM
assay to genotype bt
9J mice (see Materials and Methods). We
determined that bt
9J is the same strain as Mutant Mouse Resource
Center (MMRC) strain #183 (Figure 1B). Although the missense
mutations in bt
9J, bt
Mri1, and bt affect different domains of
ADAMTS20, these and other bt alleles are recessive and exhibit
very similar phenotypes, strongly suggesting they act as functional
null alleles.
Initial Specification and Migration of Melanoblasts Is not
Disrupted in bt
9J/bt
9J Embryos
White spotting of mouse coats is typically caused by defective
melanoblast development during embryogenesis. In order to
elucidate when and how Adamts20 affects melanoblast develop-
ment, melanoblast distribution in bt
9J/bt
9J embryos was examined.
We generated C57BL/6 mice containing a Dct-LacZ transgene,
which marks specified melanoblasts, and crossed these onto a
C57BL/6 bt
9J/bt
9J background [18,32]. Since there are no
phenotypes associated with bt
9J/+ adult animals, this heterozygous
genotype served as a control for this study.
Author Summary
Mice with black and white coat coloration patterns have
long been favorites of mouse fanciers and geneticists alike.
Analysis of mouse coat color mutants has yielded
important insights into normal developmental pathways
as well as human disease processes. In this study we have
investigated how mutations in a secreted metalloprotease,
Adamts20, result in mice with white belts in their lumbar
region, even though Adamts20 is not expressed in the
pigment producing cells. Our findings suggest that the
belting pattern is due to a combination of increased
pigment cell death, decreased pigment cell number in the
trunk, and functional overlap of closely related metallo-
proteases. Adamts20 mutants have disrupted function of
Kit, a protein that regulates pigment cell development, as
well as alterations in the extracellular matrix that surrounds
the pigment cells. These findings have implications both
for our understanding of general mechanisms of pigment
cell development as well as for new biological functions of
secreted metalloproteases.
Figure 1. The bt
9J/bt
9J mouse contains a mutation in Adamts20. (A) An image of a bt
9J/bt
9J mouse (left) and a C57BL/6 mouse (right). (B) A
representative result from a genotyping assay for the following genotypes: bt
9J/bt
9J (red triangle), bt
9J/+ (green square), wild-type (C57BL/6) (blue
diamond), and water control (grey circle).
doi:10.1371/journal.pgen.1000003.g001
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9J/
+;Dct-LacZ and bt
9J/bt
9J;Dct-LacZ embryos at E11.5 through
E16.5 (Figure S1 and Figure 2). In E11.5 and E12.5 control
embryos, melanoblasts had completed their initial migration from
the neural tube and were distributed evenly across the dorsal and
lateral surfaces of the embryo (Figures S1 and Figure 2A and 2C).
A similar distribution pattern in E11.5 and E12.5 bt
9J/bt
9J
embryos was observed (Figures S1 and Figure 2B and 2D).
Quantification of melanoblasts in the head and the presumptive
belt region of the trunk of E12.5 whole mount embryos showed no
difference in melanoblast number between control and bt
9J/bt
9J
embryos (Table 1, boxes in Figure 2A and 2C). These results show
that initial specification and migration of NC-derived melanoblasts
is not disrupted in bt
9J/bt
9J animals.
Melanoblast Distribution Is Reduced only in the Trunk of
bt
9J/bt
9J Embryos
Since there was no defect in younger embryos, melanoblast
distribution in bt
9J/+; Dct-LacZ and bt
9J/bt
9J;Dct-LacZ E13.5-
E16.5 embryos was compared (Figure 2E–2P). In E13.5 and E14.5
bt
9J/+;Dct-LacZ embryos, the melanoblast population had ex-
panded throughout the embryo and melanoblasts were distributed
uniformly across dorsal and lateral surfaces of the trunk (Figure 2E,
2G, 2I, and 2K). In contrast, melanoblast distribution was
specifically reduced in the trunk of E13.5 and E14.5 bt
9J/
bt
9J;Dct-LacZ embryos (Figure 2F, 2H, 2J, and 2L). Quantitation
of the head and trunk region of E13.5 and E14.5 bt
9J/bt
9J;Dct-
LacZ embryos confirmed that the melanoblast defect was limited
to the trunk (Table 1, boxes in Figure 2E, 2G, 2I, 2K)
(p=0.0000002 at E13.5, p=0.000096 at E14.5). By E15.5 and
E16.5, melanoblasts were distributed evenly on both dorsal and
ventral surfaces of bt
9J/+;Dct-LacZ embryos (Figure 2M and 2O).
However bt
9J/bt
9J;Dct-LacZ embryos displayed a notable absence
of melanoblasts on both surfaces in the region corresponding to
the future belt (Figure 2N and 2P). Melanoblast distribution in the
head and tail regions was similar between E16.5 bt
9J/+;Dct-LacZ
and bt
9J/bt
9J;Dct-LacZ embryos (Figure 2O and 2P). Close
examination of the belt region in E16.5 bt
9J/bt
9J;Dct-LacZ
embryos showed no accumulation of melanoblasts at the edges
of the belt, as might be expected if migration into this region were
impaired (Figure S2). Collectively, these analyses of the melano-
blast distribution in bt
9J/bt
9J animals reveal the following: the
Figure 2. Melanoblast distribution is defective in whole mount E13.5 and older bt
9J/bt
9J embryos. (A–P) Images of b-galactosidase
stained whole mount bt
9J/+;Dct-LacZ (A,C,E,G,I,K,M,O) and bt
9J/bt
9J;Dct-LacZ embryos (B,D,F,H,J,L,N,P). Shown are E12.5 embryos (A,B), E12.5 trunks
(C,D), E13.5 embryos (E,F), E13.5 trunks (G,H), E14.5 embryos (I, J), E14.5 trunks (K, L), E15.5 trunks (M,N) and E16.5 embryos (O,P). Each image is
representative of at least 12 embryos. Boxes in A, C, E, G, I, K indicate regions in which melanoblasts were quantitated; the indicated regions were
quantitated in both bt
9J/+;Dct-LacZ and bt
9J/bt
9J;Dct-LacZ embryos (see Table 1). Scale bars are: (A,B,E,F,I,J,O,P) 2 mm, (C,D,G,H,K,L,M,N) 1 mm.
doi:10.1371/journal.pgen.1000003.g002
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only in the trunk region (the location of the presumptive belt), and
dorso-lateral melanoblast migration is not impaired.
Melanoblasts Are Present in All Skin Compartments of
bt
9J/bt
9J Embryos
The melanoblast defect is first observed at E13.5, coincident
with the timing of melanoblast migration from the dermis into the
epidermis, and with generalized dermal expression of Adamts20
[12,15]. Therefore we hypothesized that Adamts20 may be
required for normal distribution of melanoblasts in dermal and
epidermal compartments of the skin. To address this, melanoblasts
were quantified in the dermis, epidermis, and dermal-epidermal
border in E13.5 trunk sections (Figure 3A and Table 2) (see
Materials and Methods). In control trunk sections (n=178) we
observed an average of 33.6 melanoblasts per section, whereas in
bt
9J/bt
9J;Dct-LacZ sections (n=179) there was an average two-fold
reduction in melanoblast number (15.9 per section, p,0.0001)
(Table 2). This finding is consistent with the analyses of whole
mount embryos (see Table 1 and Figure 2E–2H). However, the
relative distribution of melanoblasts within each of the skin layers
in bt
9J/bt
9J;Dct-LacZ embryos did not differ significantly from bt
9J/
+;Dct-LacZ control embryos (p=0.056) (Figure 3B). These results
show that while melanoblast number is significantly reduced in the
lumbar region of bt
9J/bt
9J embryos, melanoblast migration from
the dermis into the epidermis is unaffected.
Table 1. Quantitation of melanoblasts in whole mount
embryos.
Age Location bt
9J/+ bt
9J/bt
9J P value
E12.5 Eye 162685 (16) 190648 (19) 0.13241
Trunk 1626102 (16) 197659 (19) 0.11472
E13.5 Eye 171627 (10) 159618 (10) 0.25806
Trunk 105619 (10) 42614 (10) 0.0000002 **
E14.5 Eye 128636 (8) 134630 (10) 0.35728
Trunk 220669 (8) 56623 (10) 0.000096 **
Shown are the average number of melanoblasts quantitated, standard
deviations, and the number of samples in parentheses. P values are included
with ** indicating highly significant values. The regions quantitated are
represented in Figure 2 and described in the Materials and Methods.
doi:10.1371/journal.pgen.1000003.t001
Figure 3. Melanoblast distribution in the skin layers of E13.5 bt
9J/bt
9J embryos is normal. (A) A cartoon representation of an E13.5 whole
mount embryo showing the region between the fore- and hind-limbs from which 16 mm trunk sections were analyzed. (B) Pie charts representing the
melanoblast distribution in the dermis (blue), epidermis (red), and dermal/epidermal border (yellow) from E13.5 bt
9J/+ (top) and bt
9J/bt
9J (bottom)
sections with the total number of melanoblasts indicated in parentheses (n=2 embryos, each genotype). There was no significant difference in
melanoblast distribution between bt
9J/+ and bt
9J/bt
9J embryos (p=0.056).
doi:10.1371/journal.pgen.1000003.g003
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9J/bt
9J Embryos Exhibit Normal Melanoblast
Proliferation but Defective Melanoblast Survival
At E13.5, whenthe defectinmelanoblast development inbt
9J/bt
9J
embryos is first apparent, melanoblasts are undergoing dramatic
increases in cell proliferation [18]. To assess if the bt phenotype is
caused by reduced melanoblast proliferation in the trunk region of
bt
9J/bt
9J embryos, the mitotic index of melanoblasts at E13.5 was
examined in bt
9J/+;Dct-LacZ and bt
9J/bt
9J;Dct-LacZ trunk sections
(Figures 3A and 4). Melanoblasts undergoing mitosis were identified
by co-expression of b-galactosidase and phospho-histoneH3 (PH3)
(Figure 4A–4C). The average percentage of dividing melanoblasts in
control and bt
9J/bt
9J sections was not significantly different (2.94%
and 3.03% respectively, p=0.9067) (Figure 4G), suggesting that the
melanoblast reduction in bt
9J/bt
9J embryos is not a consequence of
abnormal proliferation.
The reduced number of melanoblasts in the trunk region of
E13.5 bt
9J/bt
9J;Dct-LacZ embryos could also be due to a failure of
melanoblasts to survive [33]. To examine this, the apoptotic index
of melanoblasts was quantitated from cells co-expressing b-
galactosidase and cleaved-caspase3 (CC3) (Figures 3A and 4D–
4F). The average percentage of apoptotic melanoblasts was
significantly increased in bt
9J/bt
9J;Dct-LacZ sections relative to
bt
9J/+;Dct-LacZ sections (compare 8.4% to 1.2%, p,0.00005)
(Figure 4H, Table 2). Apoptotic melanoblasts were apparent in
both dorsal and ventral skin in control and mutant embryos. In
addition, no significant differences were seen in the distribution of
apoptotic, CC3+melanoblasts in the three skin compartments, as
follows: dermal (bt
9J/bt
9J=77.8%; control=82.4%), epidermal
(bt
9J/bt
9J=14.8%; control=5.8%), and dermal/epidermal (bt
9J/
bt
9J=7.4%; control=11.85%), (p=0.6133). These results show
that Adamts20 is required for melanoblast survival in all cell layers
of the trunk at E13.5.
Adamts20 is expressed along the length of the embryo, yet the
spotting phenotype in adult mice is evident only in the lumbar
region. Therefore we examined melanoblast number and
melanoblast apoptosis in a region outside of where the belt occurs,
in the head (Table 2). In normal embryos, the density of
melanoblasts is not the same in all regions, as previously described
[34–37]. As expected, quantitation of melanoblasts in control
embryos demonstrated that there were over three-fold more total
melanoblasts in the head region than in the trunk (compare 110
versus 33.6, p=0.0001). There was no difference in melanoblast
number in the head of control and bt
9J/bt
9J;Dct-LacZ embryos
(Table 2), similar to what was seen in whole mount analyses.
The apoptotic index of melanoblasts varied in different regions
of control embryos as well as between control and mutant embryos
(Table 2). In control embryos, melanoblast apoptosis was lower in
the head than in the trunk. Comparing control and bt
9J/bt
9J
embryos, we found that apoptosis was increased in the head
although to a lesser extent than observed in the trunk. This result
indicates that Adamts20 is required for melanoblast survival
throughout the embryo even though it does not result in white
spotting in the head.
Melanoblasts in bt
9J/bt
9J Skin Fail To Respond to sKitl
Melanoblast survival is dependent upon Kit activation [20,38] by
Kit ligand (Kitl), which is expressed in the dermis in a similar
temporal and spatial pattern to Adamts20 [12,21,24–26]. We
hypothesized that Adamts20 regulates melanoblast survival through
modulation of Kit signaling, and assessed the effects of altered Kit
signaling upon the extent of white spotting in bt
9J/bt
9J animals
harboring various mutant alleles of Kit (MGI: 96677) or Kitl (MGI:
96974). Kit
tm1Alf/+ mice contain a null mutation in Kit and have
primarily ventral spotting [39–41]. As depicted in Figure 5, bt
9J/
bt
9J;Kit
tm1Alf/+ mice exhibited dramatically wider dorsal and ventral
belts in comparison to bt
9J/bt
9J mice or Kit
tm1Alf/+ mice alone
(Figure 5A and 5B). The increased spotting was a synergistic effect
rather than an additive one (compare 46.9% of dorsal and ventral
surfaces in bt
9J/bt
9J;Kit
tm1Alf/+ with 11.2% and 9.1% in Kit
tm1Alf/+
and bt
9J/bt
9J, respectively). Synergistic increases inspotting werealso
observed in bt
9J/bt
9J mice carrying mutant alleles of Kitl.
Heterozygosity for either Kitl
Sl, a null allele, or Kitl
Sl-d, a deletion
that generates short soluble Kitl but not membrane–bound Kitl,
combined with homozygosity for bt
9J resulted in synergistically
increased spotting (Figure 5C and 5D) [42,43]. In contrast, bt
9J/bt
9J
mice carrying a mutation in Mitf (bt
9J/bt
9J;Mitf
Mi/+) (MGI: 104554)
exhibited no synergistic spotting (Figure 5E). These results show that
decreasing Kit signaling exacerbates the bt
9J/bt
9J phenotype.
Heterozygous Kit
W-v mutations reduce melanoblast number
beginning at E10.5 [18], which is three days prior to the onset of
the melanoblast defect in bt
9J/bt
9J. To determine if decreasing Kit
signaling in bt
9J/bt
9J embryos would lead to an earlier defect in
melanoblast development than seen in bt
9J/bt
9J alone, we
examined E12.5 bt
9J/+;Kit
tm1Alf/+ and bt
9J/bt
9J;Kit
tm1Alf/+ embryos
(Figure S3). Since the Kit
tm1Alf mutation is a LacZ knock-in at the Kit
locus, we monitored melanoblasts using b-galactosidase staining.
There was no detectable difference in Kit-positive melanoblast
distribution between bt
9J/+;Kit
tm1Alf/+ and bt
9J/bt
9J;Kit
tm1Alf/+
embryos at E12.5. These results demonstrate that the synergistic
defect in melanoblast development does not precede the onset of
the bt phenotype at E13.5.
The synergistic interaction studies indicate that Kit signaling
may be disrupted in Adamts20 mutant animals. To test if
melanoblasts in bt
9J/bt
9J embryos could respond to sKitl we used
an ex vivo embryonic skin explant assay using dorsal trunk skin
from E13.5 embryos [44–46]. Observation of bt
9J/+;Dct-LacZ and
bt
9J/bt
9J;Dct-LacZ skin after four days in culture demonstrated that
Table 2. Quantitation of Melanoblasts in sections through the head and trunk at E13.5.
Location Genotype Total sections analyzed
Average number
Melanoblasts/section
Average % apoptotic
Melanoblasts/section
Head bt
9J/+ 40 110 (622) 0.3 (60.6)
bt
9J/bt
9J 45 117 (636) NS 1.2 (62.2)**
Trunk bt
9J/+ 178 33.6 (620) 1.2 (62.6)
bt
9J/bt
9J 179 15.9 (614)** 8.4 (616.9)**
At least 3 embryos of each genotype were analyzed. For the head, only horizontal sections containing one or both eyes were included. For the trunk, horizontal sections
corresponding to regions shown in Figure 3 were included. The standard deviations are included in parentheses. The results of statistical analyses comparing bt
9J/+ and
bt
9J/bt
9J are included (NS=not significant and **=p,0.0001, which is highly significant).
doi:10.1371/journal.pgen.1000003.t002
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melanoblast colonization and the bt defect (Figure 6). Melanoblasts
in the control skin entered hair follicles and were distributed
evenly across the explant (n=5) (Figure 6A). While some
melanoblasts survived and migrated into hair follicles in the
bt
9J/bt
9J;Dct-LacZ skin, in a large domain of the explant the
melanoblasts were reduced (n=5) (Figure 6B), similar to the
phenotype of whole mount E16.5 bt
9J/bt
9J;Dct-LacZ embryos
(Figure 2O and 2P).
Previous studies showed that melanoblasts within embryonic skin
cultures respond to soluble Kitl (sKitl) [44] and that sKitl promotes
melanoblast survival in NC cultures [38]. ADAMTS20 could be
required for proteolytic cleavage of Kit or Kitl, or for modifying
additional molecules necessary for Kit signaling. To test if Kit
signaling was defective in bt
9J/bt
9J embryos, we asked whether
melanoblasts in bt
9J/bt
9J embryos could respond to sKitl and
whether sKitl could rescue the bt phenotype. Similar to studies by
Jordan et. al, an increase in melanoblast number and colonization of
hair follicles was observed in control skin exposed to sKitl as
compared to FBS alone (Figure 6C, n=5). In contrast, exposure of
bt
9J/bt
9J;Dct-LacZskin(n=7) tosKitl didnot restore melanoblaststo
the presumptive belt (Figure 6D). Interestingly, melanoblasts at the
rostral and caudal regions of the trunk did not increase in number,
even though these are outside of the expected belt. These results
show that in the absence of Adamts20, melanoblasts are unable to
respond to sKitl, indicating that Kit signaling is disrupted in bt
9J/bt
9J
mutants. Furthermore, since sKitl could not rescue the bt phenotype,
it suggests that the melanoblast defect in bt
9J/bt
9J animals is not
caused by defective cleavage of Kitl.
ADAMTS20 Cleaves Versican in vitro and Is Necessary for
Versican Cleavage in vivo
We explored the possibility that Adamts20 could regulate
melanoblast survival through additional pathways. One of the
best-understood activities of ADAMTS proteases is processing of
Figure 4. Melanoblast proliferation and apoptosis in bt
9J/+ and bt
9J/bt
9J embryos. (A–F) Representative immunofluorescence images
depicting 16 mm trunk sections from bt
9J/bt
9J E13.5 embryos assayed for proliferation (A–C) and apoptosis (D–F). Proliferating melanoblasts were
identified by staining sections for LacZ (cytoplasmic red, A) and PH3 (nuclear green, B), and their co-localization together with nuclear DAPI staining
(blue, C). Apoptotic melanoblasts were identified by staining sections for LacZ (cytoplasmic red, D) and CC3 (cytoplasmic green, E), and their co-
localization together with DAPI (blue, F). (G–H) The Y axis (%Dct+PH3+ and %Dct+CC3) indicates the average percentage of total melanoblasts per
section that are PH3 positive (G) or CC3 positive (H), for bt
9J/+ (blue) and bt
9J/bt
9J (red) E13.5 embryos (n=5 embryos for each genotype). The total
number of sections and melanoblasts analyzed are listed beneath each graph, as well as the standard deviations. Asterisks indicate highly significant
P values. The scale bars are: (A–F) 50 mM.
doi:10.1371/journal.pgen.1000003.g004
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related phylogenetically to ADAMTS metalloproteases that
specifically process chondroitin sulfate proteoglycans (CSPGs)
[1,2,47]. Although no substrates for ADAMTS20 have been
identified, the CSPG versican is enriched in the skin and
implicated in NC development, making it an excellent candidate
substrate of ADAMTS20 [48–52].
We examined Versican and Adamts20 expression by whole mount
in situ hybridization in wild-type embryos. At E12.5, when
melanoblasts are widely distributed in the trunk, both Versican
and Adamts20 are expressed broadly across the trunk, overlapping
in many regions of the skin and the developing mammary ducts
(data not shown). Since both versican and ADAMTS20 are
secreted proteins, the expression patterns of their RNAs relative to
each other and to melanoblasts support the possibility of a
functional relationship in vivo.
We assessed the ability of ADAMTS20 to process versican by
expressing ADAMTS20 in 293 cells, and subsequently incubating
these cells with versican (Figure 7A). Versican is alternatively spliced
to generate four isoforms, with VersicanV1 being the dominant
variant in adult skin [53–56]. Versican cleavage was examined
using anti-DPEAEE antibody, which specifically recognizes the
neo-epitope generated by ADAMTS cleavage of versicanV1
(70 KDa) [57]. While secreted media from 293 cells alone
exhibited little to no cleavage of versican, versican processing
was evident in secreted media from 293 cells expressing Adamts20
(Figure 7A). As a positive control, cleaved versican was also evident
in secreted media from cells expressing Adamts9, which has
previously been shown to process versican [47]. These results show
that in vitro, versican is a substrate for cleavage by ADAMTS20.
Analysis of skin extracts from the dorsal trunk of E15.5 bt
9J/+
and bt
9J/bt
9J embryos showed ADAMTS20 is also necessary for
Figure 5. bt
9J/bt
9J animals exhibit synergistic spotting with heterozygous mutations in the Kit pathway. (A–E) Shown are representative
dorsal and ventral images of mice (top and middle row, respectively). The genotypes and number of animals (n) analyzed were: (A) bt
9J/bt
9J (n=31),
(B) Kit
tm1Alf/+ (n=14) and bt
9J/bt
9J;Kit
tm1Alf/+ (n=15), (C) Kitl
Sl/+ (n=24) and bt
9J/bt
9J;Kitl
Sl/+ (n=17), (D) Kitl
Sl-d/+ (n=6) and bt
9J/bt
9J;Kitl
Sl-d/+(n=6), and
(E) Mitf
Mi/+ (n=8), and bt
9J/bt
9J;Mitf
Mi/+ (n=13). Below are graphs showing quantitation of the average proportion of white spotting with standard
deviations. P values represent comparisons of spotting between compound mutants and bt
9J/bt
9J animals, and between compound mutants and Kit
mutants. Asterisks indicate highly significant values.
doi:10.1371/journal.pgen.1000003.g005
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70 KDa band were reduced in bt
9J/bt
9J extracts compared to
control extracts (n= 4 experiments). We also observed a reduction
in levels of a 220 KDa band corresponding to the V0 isoform (data
not shown). In contrast, there was no alteration in total versican,
which was assessed using a GAG b antibody that recognizes the
GAG b domains of full-length versicanV0 and V1 (Figure 7B).
Collectively, these results show that ADAMTS20 cleaves versican
in vitro and that it is required for versican cleavage in skin in vivo.
Immunofluorescence was performed to evaluate the spatial
pattern of versican cleavage in embryonic skin. Versican
expression was assessed on trunk sections of E15.5 C57BL/6 (+/
+) and bt
9J/bt
9J embryos (Figure 7C–7H). In +/+ sections, cleaved
versican was evident in the dermal mesenchyme and was enriched
in the proliferating basal layer of the epidermis (arrow in
Figure 7C) but was excluded from the outermost layer of the
epidermis, in a similar pattern to that of intact versican in adult
human skin [56]. In contrast to +/+ sections, bt
9J/bt
9J sections
displayed a dramatic reduction in cleaved versican in the
epidermis (Figure 7D). Inclusion of the DPEAEE peptide in the
staining procedure demonstrated the specificity of the antibody for
this peptide (Figure 7E and 7F). Total versican expression was
similar in both +/+ sections and bt
9J/bt
9J sections, with high
expression in the basement membrane, dermis, and dermal
condensations, but lower levels in the epidermis (Figure 7G and
7H). Outside of the belt region, at the level of the forelimb, the
levels of cleaved versican in bt
9J/bt
9J sections were reduced relative
to wild-type, but not to the same extent as seen in the trunk
(Figure 7I and 7J). Together these results show that in bt
9J/bt
9J
embryos, levels of processed versican, but not total versican, are
reduced in the skin of the embryonic trunk, and show that
ADAMTS20 is necessary for versican remodeling during mela-
noblast development.
Adamts9 and Adamts20 Act Cooperatively To Regulate
Melanoblast Development
Although Adamts20 is expressed across the length of the embryo
[12], only the lumbar region of the trunk in bt
9J/bt
9J mutants
shows dramatic reduction of melanoblasts and white spotting.
Given that ADAMTS20 belongs to a large family of closely
related metalloproteases, we reasoned that partial redundancy
with other metalloproteases might account for the higher
proportion of melanoblasts surviving outside of the lumbar
region. The two closest Adamts20 homologs, Adamts5 (GeneID:
23794) and Adamts9, are both expressed in the embryonic skin
along the length of the embryo and are both versicanases, making
them excellent candidates for regulating melanoblast development
[47,58,59](Bon-Hun Koo and S.S. Apte, unpublished data). To
test if these metalloprotease genes were functionally redundant
with Adamts20, we evaluated the extent of white spotting in
mutants lacking Adamts20 and either Adamts9 (Adamts9
ko)o rAdamts5
(Adamts5
ko).
Adamts9
ko homozygotes are lethal prior to gastrulation (H.
Enomoto and S. Apte, submitted) therefore we used Adamts9
ko
heterozygotes to examine a functional overlap between Adamts9 and
20. While mice heterozygous for mutation of Adamts20 and 9 are
viable, bt
9J/bt
9J;Adamts9
ko/+ animals die shortly after birth (H.
Enomoto and S. Apte, submitted). We examined pigmentation in
newborn animals that were wild-type, bt
9J/+;Adamts9
ko/+,b t
9J/bt
9J,
or bt
9J/bt
9J;Adamts9
ko/+. Skin pelts containing dorsal and ventral
surfaces and spanning the entire trunk region were removed from
newbornpups(Figure8A).Althoughnotexternallyobviousuntil4–5
days after birth, melanoblasts can be seen as clusters of pigmented
cells on the dermal side of the P0 epidermis. In all skin samples,
pigmentation was apparent primarily on dorsal surfaces as shown by
schematicrepresentationsinFigure8B–8E.Intheskinfrom+/+and
bt
9J/+;Adamts9
ko/+ animals, pigmentation was distributed uniformly
Figure 6. Melanoblasts in bt
9J/bt
9J skin do not respond to soluble Kitl. (A–D) Images of b-galactosidase stained skin cultures grown from
E13.5 bt
9J/+;Dct-LacZ (A,C) or bt
9J/bt
9J;Dct-LacZ (B,D) embryos, and treated with either 5% FBS (A,B) or 5% FBS+Kitl (C,D). Brackets indicate the
presumptive belt regions in bt
9J/bt
9J skin. The scale bars are: (A–D) 0.5 mm.
doi:10.1371/journal.pgen.1000003.g006
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each) (Figures 8B and 8C). In the bt
9J/bt
9J skin samples (n=6), a
partial de-pigmentation was observed on about 50% of the anterior-
posterior length, consistent with the likely boundaries of ‘‘belted’’
and ‘‘non-belted’’ regions (Figure 8D). However, in the bt
9J/
bt
9J;Adamts9
ko/+ skin samples (n=5), de-pigmentation was apparent
on 75% of the anterior-posterior length (Figure 8E). Our analyses
showed a statistically significant increase in the severity of de-
pigmentation in bt
9J/bt
9J;Adamts9
ko/+ skin compared to that seen in
bt
9J/bt
9J skin (Figure 8F). In contrast, the pigmentation phenotype in
bt
Bei1/bt
Bei1;Adamts5
ko/Adamts5
komicewassimilartothatofbt
Bei1/bt
Bei1
animals indicating that loss of Adamts5 does not exacerbate the bt
9J/
bt
9J phenotype and that unlike Adamts9, Adamts5 does not participate
in melanoblast development (D. McCullough and S. Apte,
unpublished data).
In order to assess melanoblast development in bt
9J/+;Adamts9
ko/
+and bt
9J/bt
9J;Adamts9
ko/+ mice, E13.5 embryos were examined
using in situ hybridization with Pmel17 (GeneID: 20431), a marker
specific for melanoblasts. Similar to what was observed in newborn
skin, there was a significant reduction in melanoblasts in the trunk
region of bt
9J/bt
9J;Adamts9
ko/+ embryos compared to bt
9J/
+;Adamts9
ko/+ embryos (data not shown). Importantly, there was
also a significant reduction of melanoblasts in regions outside of
the trunk (Figure 8G and 8H). These results indicate that Adamts9
and Adamts20 are partially redundant during melanoblast
development not only in the trunk but in the head as well.
Figure 7. ADAMTS20 cleaves versican in vitro and in vivo. (A,B) Western analyses probed with anti-DPEAEE that recognizes the 70 KDa versican
cleavage product. (A) Protein extracts from 293 cells transfected with vector alone, Adamts20 (2 experiments) and Adamts9, and incubated with
versican. (B) Protein extracts of E15.5 day old skin from six different bt
9J/+ and bt
9J/bt
9J embryos. Anti-a-Tubulin serves as a loading control and anti-
GAG bindicates levels of total versican. (C–J) Immunofluorescence images of +/+ (C,E,G, I) or bt
9J/bt
9J (D,F,H,J) E15.5 10 mm trunk (C–H) and forelimb
(I,J) sections stained with anti-DPEAAE (C,D,I,J), anti-DPEAAE and DPEAEE peptide (E,F), and anti-GAG b (G,H). The anti-DPEAEE staining in the
proliferating layer of the epidermis (indicated by arrows) is reduced dramatically in trunk sections and reduced to a lesser extent in forelimb sections
from bt
9J/bt
9J embryos. The scale bars are: (C–F,I,J) 50 mM, (G,H) 100 mM.
doi:10.1371/journal.pgen.1000003.g007
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Analysis of mouse coat color mutants has yielded mechanistic
insights into normal developmental pathways as well as human
disease processes. In this paper we explored how mutation of
Adamts20, a secreted metalloprotease that is not expressed in
melanoblasts, can disrupt melanoblast development and cause
white spotting. The expression pattern of Adamts20, along with
studies performed on the C.elegans ortholog Gon-1, initially
suggested that Adamts20 regulated melanoblast migration [12,27–
29]. However, rather than this predicted requirement for
melanoblast migration, we have identified an unexpected role
for Adamts20 in melanoblast survival. Our results have implications
not only for understanding mechanisms of melanoblast develop-
ment and pigmentation-associated diseases but also for the
biological functions of secreted metalloproteases.
Mutation of Adamts20 Increases Melanoblast Apoptosis
The most striking alteration observed in bt
9J/bt
9J embryos was a
reduction in trunk melanoblasts beginning at E13.5. Early events
of melanoblast specification, migration, proliferation and survival
were not affected, as the number and distribution of Dct-LacZ-
positive melanoblasts was similar between control and bt
9J/bt
9J
embryos up to E12.5. This result contrasts many melanoblast
mutants including Kit, Mitf, Pax3 (MGI: 97487), Ednrb (MGI:
102720), and Sox10 (MGI: 98358), in which melanoblast defects
can be observed as early as E10.5-E11.5 [15].
Multiple lines of evidence also indicate that later stages of
melanoblast migration were not defective in bt
9J/bt
9J embryos.
Dct-LacZ-positive cells did not accumulate dorsally or in the
dermis, suggesting that melanoblast migration along the dorso-
lateral pathway and between skin layers was normal. It is also
unlikely that melanoblasts undergo cell death as a result of or
subsequent to failed migration, as apoptotic melanoblasts were
apparent in both dorsal and ventral regions of mutant embryos
and in similar proportions within dermal and epidermal
compartments. Our results also exclude a defect in the second
wave of melanoblast migration [37,60], since melanoblasts did not
accumulate at the belt edges in E16.5 embryos. Instead, our results
show that reduction of melanoblasts is due to the seven-fold
increase in apoptosis observed in the trunk region of Adamts20
mutant embryos.
Why Do Mutations in Adamts20 Cause a Belt?
We propose that the white belt occurs in Adamts20 mutants for a
combination of three factors: uneven densities of melanoblasts
along the length of normal embryos, regional differences in
apoptosis, and functional redundancy with other metalloproteases.
In wild-type animals there are fewer embryonic melanoblasts in
the trunk relative to other areas of the body, as shown in this study
and by others [17,34–37]. Related to this, many of the coat color
mutants exhibit spotting in the lumbar level of the trunk suggesting
that melanoblasts in this region are particularly sensitive to genetic
perturbation, perhaps due to reduced numbers. This suggests that
if melanoblast numbers were further reduced along the trunk in
Adamts20 mutants, the resulting belt would be wider. Indeed this
was the case since genetic interactions of bt
9J/bt
9J with Kit
mutations caused a wider belt as opposed to increased spotting in
the head.
Second, Adamts20 is required for melanoblast survival through-
out the embryo, consistent with the expression pattern of Adamts20
along the length of the embryo. In bt
9J/bt
9J embryos, we found
significant increases in apoptosis in both head and trunk regions.
Importantly, the proportion of melanoblasts undergoing apoptosis
was much more pronounced in the trunk than in the head. Thus a
combination of increased apoptosis and lower initial melanoblast
number in the trunk region of a bt
9J/bt
9J mutant depletes
melanoblast numbers to levels at which it cannot generate
adequate pigmentation.
Third, Adamts20 mutant animals have limited white spotting due
to functional redundancy with other metalloproteases, including
Adamts9. In a bt
9J/bt
9J background, loss of a single copy of Adamts9
results in reduced melanoblast numbers in the trunk as well as in
the head. Thus, in bt
9J/bt
9J mice, Adamts9 can compensate for
Adamts20 deficiency in regions of higher melanoblast number such
as the head. The early embryonic lethality of Adamts9
ko/Adamts9
ko
mice makes it impossible to currently assess the absolute
requirement of Adamts9 in pigmentation. However, the widespread
expression of Adamts9 in the skin paired with the dramatic defect in
melanoblast development in bt
9J/bt
9J;Adamts9
ko/+ animals predict
an even greater pigmentation defect in a homozygous background.
These future analyses will depend upon the generation of a
conditional Adamts9 knock-out in the skin.
Adamts20 Modulates Kit Signaling
Our results suggest that Adamts20 is required for melanoblast
survival at least in part through modulating Kit signaling. We show
that bt
9J/bt
9J;Kit
tm1Alf/+ mutants exhibit synergistic spotting, and
melanoblasts in bt
9J/bt
9J skin cultures are unable to respond to sKitl.
This mechanism is consistent with the requirement of Kit signaling
for melanoblast survival as well as the overlapping expression of
Adamts20, Kit and Kitl in the dermis [12,17,20,24–26,61].
Kit signaling is essential for several events in melanoblast
development beginning at E10.5 and including both migration
and survival. Yet our findings indicate that mutation of Adamts20
modulates only a subset of Kit functions, namely survival, and only
during a defined window of time, around E13.5, rather than
throughout development. This is evidenced by the fact that bt
9J/
bt
9J embryos do not show altered melanoblast development prior
to E13.5, such as seen in Kit/+ embryos [17,18]. In addition, Kit
heterozygous mutations do not exacerbate the onset of the
melanoblast defect in E12.5 bt
9J/bt
9J embryos, as would be
expected if Adamts20 were required earlier. The stage at which
Adamts20 disrupts melanoblast development may also explain why
bt mice do not exhibit extensive ventral spotting like other white
spotted mutants that impede earlier events in development.
Given these observations, it is notable that restricted disruption
of Kit, during the embryonic period associated with onset of the
Figure 8. Adamts9 and Adamts20 act redundantly to regulate pigmentation. (A) A schematic image of a newborn pup. Skin samples
(indicated by the box) were taken from the trunk region around the circumference of the animal and were flattened with a single cut on the ventral
side. (B–E) Shown on the left are cartoon representations of the pigmentation patterns and on the right are high magnification images of skin
samples from (B) +/+ (n=4), (C) bt
9J/+; Adamts9
ko/+(n=4), (D) bt
9J/bt
9J (n=6), and (E) bt
9J/bt
9J; Adamts9
ko/+(n=5) animals. Dots indicate pigmented
hair follicles. Labels for orientation of the samples are as follows: V (ventral), D (dorsal), A (anterior), and P (posterior). Images were taken by focusing
on 1/3 of the anterior-posterior length of the skin sample. (F) A graph depicting the relative score of pigmentation as described in the Materials and
Methods. The difference between bt
9J/bt
9J and bt
9J/bt
9J; Adamts9
ko/+ samples was significantly different (p=0.006). (G and H) Head images of in situ
hybridization with the melanoblast marker, Pmel17, on whole mount E13.5 bt
9J/+; Adamts9
ko/+(n=2) (G) and bt
9J/bt
9J; Adamts9
ko/+(n=2) (H) embryos.
Note there are fewer melanoblasts all over the head and particularly in the snout of bt
9J/bt
9J; Adamts9
ko/+embryos. Scale bars=0.5 mm.
doi:10.1371/journal.pgen.1000003.g008
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9J/bt
9J phenotype, results in mice with spotting phenotypes
similar to bt [23,62]. Pregnant mice injected with neutralizing Kit
antibodies between E10.5 and E13.0 give birth to mice exhibiting
white belts. In contrast, injection of these Kit antibodies into
pregnant animals prior to E10.5 and after E13.0 results in mostly
unpigmented mice.
A white belt/band is also evident in Kit
W-sh/+, Kit
W-57J/Kit
W-57J,
and Kit
W-bd/+ mice that carry mutations in Kit regulatory sequences
and cause altered Kit expression patterns [35,63,64]. In addition,
Kimura and colleagues describe belted phenotypes in Kit
tm1Ber and
Kit
tm2Ber mice containing targeted mutations of Kit at tyrosine
residues 567 and 569, amino acids essential for proper
phosphorylation and downstream signaling [65]. It is interesting
that disruption of these specific amino acids results in spotting
similar to that seen in belted mice, and we speculate that Adamts20
may be required for efficient Kit phosphorylation at these sites in
melanoblasts in vivo.
There are several possible mechanisms by which ADAMTS20
could regulate Kit signaling. ADAMTS20 could be required
directly for cleavage of either Kit and/or Kitl to produce sKitl. For
example, the ADAM family member ADAM17 (GeneID: 11491)
cleaves Kit in vitro, and ADAM17, 19 (GeneID: 8728) and 33
(GeneID: 110751) cleave Kitl [66–69]. However, sKitl did not
rescue the melanoblast defect in bt
9J/bt
9J skin cultures as would be
expected if Kitl were an essential substrate of ADAMTS20. As
further evidence that the bt phenotype is not due to defective Kitl
cleavage, bt
9J/bt
9J exhibited similar genetic interactions with both
a Kitl null allele and with KitL
Sl-d/+ animals, which produce a short
sKitl [42,43,70]. Kunisada et. al have also shown that transgenic
mice over-expressing Kitl transgene, which greatly reduces the
white spotting associated with Kit mutants, only slightly reduces the
spotting in bt
9J/bt
9J animals [71]. Taken together this suggests that
the bt phenotype is not due to defective cleavage of Kitl. Instead,
Adamts20 may regulate the interaction of Kitl with Kit, the
activation of Kit, or signaling downstream of the receptor. Future
biochemical studies will be necessary to define the exact
mechanism by which Adamts20 modulates Kit signaling.
The observation that melanoblasts in bt
9J/bt
9J trunk explants
did not exhibit any response to soluble Kitl indicates that Kit
signaling is defective, but it is important to note that this does not
exclude the possibility that Adamts20 may additionally regulate
other factors essential for melanoblast development. For example,
Adamts20 could be required to activate other pathways that act
synergistically with Kit to regulate melanoblast survival.
ECM Alterations in bt
9J/bt
9J Mice
Another possible mechanism by which Adamts20 could modulate
survival is by altering the extracellular matrix in which
melanoblasts are located. We show that bt
9J/bt
9J mutants exhibit
reduced cleavage of at least one ECM component, versican.
Versican, Adamts20, and Kitl are expressed in embryonic skin at
appropriate times and sites to regulate melanoblast development
[12,24,72]. In fact, sKitl enhances melanoblast proliferation to a
greater extent when primary NC cells are cultured on chondroitin
sulfate, suggesting that the ECM can modulate Kit signaling [73].
Taken in context of this study, it could be melanoblasts in bt
9J/bt
9J
explant cultures did not respond to sKitl because the ECM was
defective.
Versican proteolysis could influence melanoblast behavior and
Kit signaling by promoting direct interactions of Kitl with Kit
receptor. Such a scenario is analogous to heparin sulfate
proteoglycans, which modulate growth factor signaling by
sequestering ligand and promoting its receptor binding [74].
Studies of Weill-Marchesani syndrome strongly suggest
ADAMTS10 (GeneID: 81794) regulates TGF bsignaling through
its interactions with the ECM component, fibrillin-1 (GeneID:
2200) [9]. Interestingly, versican binds extracellular cytokines,
including the secreted growth factor, midkine (GeneID: 17242)
[75–77]. Future studies will reveal if versican, Kit, and Kitl
physically interact and if versican regulates Kit signaling directly.
Versican and its proteolytic products could also promote
melanoblast survival through a pathway that is independent of
Kit signaling. Versican V1 promotes survival of NIH3T3 cells and
down-regulates expression of the pro-apoptotic protein Bad
(GeneID: 12015) [78]. Expression of the versican G1 domain
protects sarcoma cells from apoptosis, and binding of the versican
G3 domain to b-Integrin promotes survival of astrocytoma cells
[79,80]. Since integrins are expressed by melanoblasts [81,82],
versican-integrin interactions are another potential mechanism by
which versican could influence melanoblast development. Since
versican mutants are embryonic lethal around E10.5 [83],
conditional models of versican as well as transgenic animals
containing constitutively cleaved and uncleaved Versican mole-
cules will be necessary to assess the requirement of versican for
melanoblast development.
ADAMTS20 and Human Disease
Given that cell survival is an integral component of melanoma
progression, ADAMTS9 and ADAMTS20 are excellent candidates
for participating in melanoma. ADAMTS20 over-expression has
not been carefully examined in melanoma, but has been observed
in brain, colon and breast tumors [47,84]. The related
metalloproteases ADAM9 (GeneID: 8754) and ADAMTS13 are
upregulated in primary melanoma tumors and in melanoma cell
lines, respectively [85,86]. Interestingly, VERSICAN and KITL
overexpression are observed in primary melanomas and levels
correlate with melanoma progression [87–91]. Given the require-
ment of Adamts20 for Kit signaling and versican cleavage, it is
intriguing to consider how dysregulation of signaling between
ADAMTS20, Kit, and versican might contribute to melanoma
progression.
Materials and Methods
Mice and Genetic Interactions
The following mouse stocks were used and kindly provided by:
Adamts20
bt-Bei1 (David Beier, Harvard Medical School),
Adamts20
bt9J (Lynn Lamoreux, Texas A&M University), Dct-LacZ,
Mi
Mi, Kit
tm1Alf, Kitl
Sl (Heinz Arnheiter, NINDS), Kit
Sl-d (Jackson
Laboratories, Bar Harbor, ME). Adamts9
ko and Adamts5
ko
knockout animals (both on a C57Bl/6 background) are described
elsewhere (D. McCullough, H. Enomoto, S. Apte, unpublished).
Quantification of white spotting was performed using Image J
software (http://rsb.info.nih.gov/ij) (NIH, Bethesda, MD) and
statistical significance of spotting calculated using ANOVA tests.
Genotyping and Sequencing
cDNA was sequenced by GeneDx (Gaithersburg, MD).
Adamts20
bt9J animals were genotyped using standard conditions
on an ABIPrism7000 using a Taqman
TM assay of genomic DNA.
For this assay, a region containing the point mutation is amplified
by PCR. Two fluorescently labeled single-stranded oligonucleo-
tides (probes), one complementary to the wild-type product, and
one complementary to the mutant product are included in the
assay. The relative amount of wild-type and mutant product is
measured by fluorescence quenched upon DNA synthesis. Allelic
discrimination was performed to detect the total levels of each
allele at the conclusion of the PCR reaction. The following cycling
ADAMTS20 Regulates Melanoblast Survival
PLoS Genetics | www.plosgenetics.org 12 2008 | Volume 4 | Issue 2 | e1000003conditions were used: 1. 95uC for 10 minutes 16,2 .9 2 uC for
15 seconds, 3. 55uC for 60 seconds (2 and 3 repeated 40 times).
The following primers and probes were used: TTCAGCACAGC-
TATTCTGGAAGAC (forward primer), GCACCTGAGGCA-
GACATACAC (reverse primer), CTTACCGAGATAGTTGTC
(VIC probe, C57BL/6 allele), and CTTACCGAAATAGTTGTC
(FAM probe, bt
9J allele) (designed using Applied Biosystems
software, Foster City, CA).
Melanoblast Quantitation
For quantitation of whole mount embryos, melanoblasts were
counted from both sides of each embryo within a 1 mm60.7 mm
field surrounding the eye or the trunk. For quantitation of
melanoblasts in E13.5 sections, Dct-LacZ expression was scored.
The mitotic index was calculated using the average number of
PH3+ melanoblasts per section divided by the average number of
total melanoblasts per section and multiplied by 100. The
apoptotic index was calculated using the average number of
CC3+ melanoblasts per section divided by the average number of
total melanoblasts per section and multiplied by 100. For
quantitation of melanoblasts in different skin compartments the
following criteria were used: melanoblasts above the basal
membrane were classified as epidermal, melanoblasts below the
basal membrane were classified as dermal, and melanoblasts
crossing the basal membrane and present in both regions were
classified as dermal/epidermal region. The following statistical
tests were used: for average number of melanoblasts in sections
and whole mount embryos (two-tailed Student’s t-test), for
proportion of total melanoblasts and apoptotic melanoblasts in
skin layers (Chi-square test of independence), for proportion of
proliferating and apoptotic melanoblasts (Fisher’s test).
Whole Mount b-Galactosidase Staining and In situ
Hybridization
b-galactosidase activity staining was performed as previously
described [41]. In situ hybridization was performed as previously
described [92] using a 1 Kb mouse Adamts20 probe [12], a 644 bp
mouse Versican V1 probe made using mouse Versican V1 cDNA (a
kind gift of Andrew Copp, UCL), a Pmel17 probe made as
previously described [92], and a 1 Kb mouse Adamts9 probe [58].
Immunofluorescence
Frozen sections were prepared from embryos fixed overnight in
4% paraformaldehyde. Staining was performed with modifications
to manufacturer’s protocol (Vector Laboratories, Burlingame,
CA), and sections were mounted using Hardset Vectashield with
DAPI (Vector Laboratories). The following antibodies were used
at 1:200: mouse anti- b galactosidase (Promega, Madison, WI),
rabbit anti-cleaved Caspase-3 (Cell Signaling, Danvers, MA),
rabbit anti-phospho-Histone H3 (Upstate Biotechnology,
Charlottesville, VA), rabbit anti-versican GAG b (Chemicon,
Temecula, CA), rabbit anti-versican V0/V1 Neo (Affinity
Bioreagents, Golden, CO), anti-mouse and anti-rabbit
rhodamine-conjugated or FITC-conjugated secondary antibodies
(Vector Laboratories).
Generation of Expression Plasmids and Versican
Digestion
Adamts20 short isoform cDNA was assembled by PCR from
E17.5 mouse embryo mRNA, sequence verified, and cloned into
pcDNAmyc-hisA+ plasmid (Invitrogen, Thousand Oaks, CA).
The expression plasmid for full-length Adamts9 was previously
described [47]. Transfected or untransfected cells were incubated
with versican as previously described [47]. Extracts of embryo skin
were prepared using a RIPA lysis buffer containing protease
inhibitor mixture (20 ml) and 2 mM phenylmethylsulphonyl
fluoride (Pierce, Rockford, IL). For analysis of total versican, cell
extracts were treated with 0.1 units chondroitinase ABC (Associ-
ates of Cape Cod, East Falmouth, MA) in 0.1 M Tris, 50 mM
NaAc for 10 minutes at 37uC. Skin extracts and conditioned
medium from transfected cells were run on 4–12% SDS-
Polyacrylamide gels (Invitrogen) and analyzed by Western blotting
using the following primary antibodies: mouse anti-myc 9E10
(Invitrogen), rabbit anti-versican GAG bat 1:1000, rabbit anti-
versican V0/V1 Neo at 1:1000, and mouse anti-a-Tubulin at
1:1000 (Sigma, St.Louis, MO); and secondary antibodies: anti-
rabbit HRP and anti-mouse HRP (Amersham, Piscataway, NJ).
Ex vivo Embryonic Skin Analysis
Dorsal skin between the forelimb and hindlimb was isolated
from E13.5 bt/+;Dct-LacZ and bt/bt;Dct-LacZ embryos with
ventral tissue portions and internal organs removed. The skin
explants were placed epidermal side up onto polyethylene
terepthlate track-etched membranes in a cell culture insert
(8.0 mm pore size, Becton-Dickinson, Franklin Lakes, NJ).
Separate cultures were established for each explant. Explants
were cultured for four days with 95% DMEM, 5% FBS (control
medium) and as noted the medium was supplemented daily with
500 ng/ml Kitl (R&D Systems, Minneapolis, MN). After a culture
period of four days, the explants were fixed in 4% paraformal-
dehyde in PBS (pH 7.4) for one hour and staining for b-
galactosidase activity was performed as previously described [41].
Newborn Skin Analysis
Skin was removed from newborn pups, fixed in 4% parafor-
maldehyde overnight and washed 36 in PBS and then analyzed
on the dermal side for pigmentation. Pigmentation was scored as
the extent of pigmentation between anterior and posterior edges of
samples, using the following scale: 1 (no pigmentation), 2 (between
0 and 25%), 3 (between 25 and 50%), 4 (between 50 and 75%), 5
(between 75% and 100%). Statistical significance was calculated
using a student’s t test.
Supporting Information
Figure S1 Melanoblast distribution is normal in bt
9J/
bt
9J E11.5 embryos. (A-D) Images of b-galactosidase stained
E11.5 bt
9J/+;Dct-LacZ (A,C) and bt
9J/bt
9J;Dct-LacZ (B,D) embry-
os. Shown are whole embryos (A,B) and trunks (C,D). The scale
bars are: (A,B) 2mm, (C,D) 1mm.
Found at: doi:10.1371/journal.pgen.1000003.s001 (8.94 MB TIF)
Figure S2 Melanoblasts do not build up at the lateral
edges of the belt in bt
9J/bt
9J E16.5 embryos. (A-D) Images
of the belt region of b-galactosidase stained E16.5 whole mount
bt
9J/+;Dct-LacZ (A,C) and bt
9J/bt
9J;Dct-LacZ (B,D) embryos.
Shown are low magnification (A,B) and high magnification
(C,D) images from four different embryos. The scale bars are:
(A,C) 1 mm, (B,D) 0.5 mm.
Found at: doi:10.1371/journal.pgen.1000003.s002 (10.38 MB
TIF)
Figure S3 Kit heterozygous mutations do not exacerbate
the bt phenotype at E12.5. Representative images of the trunks
of E12.5 bt
9J/+;Kit
tm1Alf/+(A) and bt
9J/bt
9J;Kit
tm1Alf/+ embryos
(n=6 each genotype) (B). Melanoblasts are marked using LacZ,
which is targeted to the Kit
tm1Alf locus. The scale bar is 1mm.
Found at: doi:10.1371/journal.pgen.1000003.s003 (9.47 MB TIF)
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